DE69117902T2 - Progestogen als einziges Kontrazeptivum - Google Patents

Progestogen als einziges Kontrazeptivum

Info

Publication number
DE69117902T2
DE69117902T2 DE69117902T DE69117902T DE69117902T2 DE 69117902 T2 DE69117902 T2 DE 69117902T2 DE 69117902 T DE69117902 T DE 69117902T DE 69117902 T DE69117902 T DE 69117902T DE 69117902 T2 DE69117902 T2 DE 69117902T2
Authority
DE
Germany
Prior art keywords
ketodesogestrel
desogestrel
regimen
oral contraceptive
progestogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69117902T
Other languages
English (en)
Other versions
DE69117902D1 (de
Inventor
Bennink Herman Jan Ti Coelingh
Engelbert Willem Bergink
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo NV
Original Assignee
Akzo NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8205203&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69117902(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo NV filed Critical Akzo NV
Application granted granted Critical
Publication of DE69117902D1 publication Critical patent/DE69117902D1/de
Publication of DE69117902T2 publication Critical patent/DE69117902T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
DE69117902T 1990-12-17 1991-12-12 Progestogen als einziges Kontrazeptivum Expired - Lifetime DE69117902T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP90203371 1990-12-17

Publications (2)

Publication Number Publication Date
DE69117902D1 DE69117902D1 (de) 1996-04-18
DE69117902T2 true DE69117902T2 (de) 1996-08-29

Family

ID=8205203

Family Applications (2)

Application Number Title Priority Date Filing Date
DE1999175011 Active DE19975011I2 (de) 1990-12-17 1991-12-12 Progestogen als einziges Kontrazeptivum.
DE69117902T Expired - Lifetime DE69117902T2 (de) 1990-12-17 1991-12-12 Progestogen als einziges Kontrazeptivum

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE1999175011 Active DE19975011I2 (de) 1990-12-17 1991-12-12 Progestogen als einziges Kontrazeptivum.

Country Status (20)

Country Link
US (1) US5461041A (de)
EP (1) EP0491443B1 (de)
JP (1) JPH04290829A (de)
KR (1) KR100221008B1 (de)
CN (1) CN1036834C (de)
AT (1) ATE135218T1 (de)
AU (1) AU649082B2 (de)
CA (1) CA2057714C (de)
DE (2) DE19975011I2 (de)
DK (1) DK0491443T3 (de)
ES (1) ES2087237T3 (de)
FI (1) FI98984C (de)
GR (1) GR3020180T3 (de)
IE (1) IE71202B1 (de)
LU (1) LU90341I2 (de)
NL (1) NL990003I2 (de)
NO (2) NO178686C (de)
NZ (1) NZ240969A (de)
PT (1) PT99818B (de)
ZA (1) ZA919732B (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4133680A1 (de) * 1991-10-11 1993-04-15 Metallgesellschaft Ag Stabilisierte staerke, verwendung der stabilisierten staerke und verfahren zu ihrer herstellung
DE4227989A1 (de) * 1992-08-21 1994-06-09 Schering Ag Mittel zur transdermalen Applikation enthaltend 3-Keto-desogestrel
US5395627A (en) * 1992-09-04 1995-03-07 Akzo N.V. Pharmaceutical granulate
US6407082B1 (en) * 1996-09-13 2002-06-18 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a vitamin D compound
ZA949929B (en) * 1993-12-23 1995-08-23 Akzo Nobel Nv Sugar-coated pharmaceutical dosage unit.
DE4405590C1 (de) * 1994-02-22 1995-07-20 Hesch Rolf Dieter Prof Dr Med Mittel zur postmenopausalen Hormonbehandlung
US5916593A (en) * 1994-09-22 1999-06-29 Akzo Nobel, N.V. Process of making dosage units by wet granulation
US6765002B2 (en) 2000-03-21 2004-07-20 Gustavo Rodriguez Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium
US6028064A (en) * 1996-09-13 2000-02-22 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of progestin products
US6034074A (en) 1996-09-13 2000-03-07 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a Vitamin D compound
US6511970B1 (en) 1996-09-13 2003-01-28 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium
WO1999051214A2 (en) * 1998-04-07 1999-10-14 Akzo Nobel N.V. Progestogen-only contraceptive kit
AU5619399A (en) * 1998-08-11 2000-03-06 Akzo Nobel N.V. Progestogen-only contraceptive kit providing good cycle control
US20050113351A1 (en) * 2000-03-21 2005-05-26 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US20040176336A1 (en) * 2000-03-21 2004-09-09 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US20010044431A1 (en) * 2000-03-21 2001-11-22 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
GB0114746D0 (en) * 2001-06-16 2001-08-08 Boots Co Plc Medicinal composition
US6574033B1 (en) 2002-02-27 2003-06-03 Iridigm Display Corporation Microelectromechanical systems device and method for fabricating same
TW200403075A (en) * 2002-05-29 2004-03-01 Akzo Nobel Nv Progestagenic dosage units
ES2312996T3 (es) * 2003-04-29 2009-03-01 N.V. Organon Proceso de solidificacion con antidisolvente.
DE102005053771A1 (de) * 2005-11-09 2007-05-10 Grünenthal GmbH Darreichform zur hormonalen Kontrazeption
DE202010010589U1 (de) 2010-07-22 2010-10-14 Bayer Schering Pharma Aktiengesellschaft Estrogenfreie Formulierung zur oralen Kontrazeption, bevorzugt verwendbar für Frauen mit bewusster/unbewusster Laktoseintoleranz oder mit bewusster laktosefreier Kontrazeption
EP2730284A1 (de) * 2012-11-12 2014-05-14 Naari AG Zusammensetzung mit ausschließlich Levonorgestrel zur optimierten oralen Empfängnisverhütung mit definiertem Levonorgestrelgehalt, Dosierungsschema und pharmazeutisches Präparat
WO2017000081A1 (zh) * 2015-06-30 2017-01-05 上海交通大学 Etonogestrel在制备抗前列腺癌产品中的应用
US11679114B2 (en) 2021-07-26 2023-06-20 Navad Life Sciences Pte Progestogen-only oral contraception

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4066757A (en) * 1973-03-26 1978-01-03 Ortho Pharmaceutical Corporation Oral contraceptive regimen
ES2054784T3 (es) * 1987-08-08 1994-08-16 Akzo Nv Un metodo para la fabricacion de un implante.

Also Published As

Publication number Publication date
ES2087237T3 (es) 1996-07-16
NZ240969A (en) 1994-04-27
FI915913A0 (fi) 1991-12-16
ZA919732B (en) 1992-09-30
EP0491443A1 (de) 1992-06-24
AU649082B2 (en) 1994-05-12
DK0491443T3 (da) 1996-06-24
LU90341I2 (fr) 1999-03-29
PT99818A (pt) 1992-11-30
CN1036834C (zh) 1997-12-31
NO914970D0 (no) 1991-12-16
JPH04290829A (ja) 1992-10-15
EP0491443B1 (de) 1996-03-13
CA2057714A1 (en) 1992-06-18
CN1062465A (zh) 1992-07-08
NO178686C (no) 1996-05-15
NL990003I1 (nl) 1999-04-01
NO178686B (no) 1996-02-05
CA2057714C (en) 2002-10-01
NO2002013I2 (no) 2007-02-26
US5461041A (en) 1995-10-24
FI98984B (fi) 1997-06-13
FI98984C (fi) 1997-09-25
ATE135218T1 (de) 1996-03-15
GR3020180T3 (en) 1996-09-30
IE914271A1 (en) 1992-06-17
FI915913A (fi) 1992-06-18
NL990003I2 (nl) 1999-05-03
IE71202B1 (en) 1997-02-12
KR920011514A (ko) 1992-07-24
NO914970L (no) 1992-06-18
KR100221008B1 (ko) 1999-09-15
DE69117902D1 (de) 1996-04-18
AU8967891A (en) 1992-06-18
DE19975011I2 (de) 2005-05-04
PT99818B (pt) 1999-05-31

Similar Documents

Publication Publication Date Title
ATE135218T1 (de) Progestogen als einziges kontrazeptivum
DK0402950T3 (da) Behandling af postmenopausale ulemper
EP0136011A3 (de) Verfahren zur hormonalen Behandlung von Störungen in der Peri-Menopause, Menopause und Post-Menopause und Verpackung mit multiplen Präparaten dafür
LU90634I2 (fr) Gestodene et ethinylestradiol/minesse
MX9804395A (es) Proceso y equipo anticonceptivos para mamiferos hembra, que comprenden una combinacion de gestageno y estrogeno.
RU94040720A (ru) Экстроген (прогестин) антипрогестиновый, способ пероральной контрацепции и регулирования менструаций, фармацевтическая композиция и набор лекарственных средств
MX9703018A (es) Antagonistas de progesterona competentes para regular la fertilidad femenina segun se requiera.